These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ. Mov Disord; 2004 Jun; 19(6):630-40. PubMed ID: 15197700 [Abstract] [Full Text] [Related]
3. The effect of small vessel disease on motor and cognitive function in Parkinson's disease. Shibata K, Sugiura M, Nishimura Y, Sakura H. Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957 [Abstract] [Full Text] [Related]
4. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease. Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Tan L, Kandiah N. Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577 [Abstract] [Full Text] [Related]
5. Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease. Schwartz RS, Halliday GM, Soh D, Cordato DJ, Kril JJ. J Clin Neurosci; 2018 Dec; 58():70-74. PubMed ID: 30327218 [Abstract] [Full Text] [Related]
6. Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients. Loos CM, Klarenbeek P, van Oostenbrugge RJ, Staals J. PLoS One; 2015 Dec; 10(9):e0137323. PubMed ID: 26352265 [Abstract] [Full Text] [Related]
7. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. Utter S, Tamboli IY, Walter J, Upadhaya AR, Birkenmeier G, Pietrzik CU, Ghebremedhin E, Thal DR. J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559 [Abstract] [Full Text] [Related]
8. What are the differences between younger and older patients with symptomatic small vessel disease? Pavlović AM, Pekmezović T, Zidverc-Trajković J, Jovanović Z, Mijajlovic M, Pavlović D, Tomić G, Sternić N. Clin Neurol Neurosurg; 2011 Nov; 113(9):762-7. PubMed ID: 21890262 [Abstract] [Full Text] [Related]
9. Vascular pathology in patients with idiopathic Parkinson's disease. Rektor I, Goldemund D, Sheardová K, Rektorová I, Michálková Z, Dufek M. Parkinsonism Relat Disord; 2009 Jan; 15(1):24-9. PubMed ID: 18403246 [Abstract] [Full Text] [Related]
10. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. de la Monte SM, Wells SE, Hedley-Whyte T, Growdon JH. Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531 [Abstract] [Full Text] [Related]
11. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases. Ghebremedhin E, Rosenberger A, Rüb U, Vuksic M, Berhe T, Bickeböller H, de Vos RA, Thal DR, Deller T. J Neuropathol Exp Neurol; 2010 May; 69(5):442-8. PubMed ID: 20418782 [Abstract] [Full Text] [Related]
12. White matter lesions and depression in patients with Parkinson's disease. Petrovic IN, Stefanova E, Kozic D, Semnic R, Markovic V, Daragasevic NT, Kostic VS. J Neurol Sci; 2012 Nov 15; 322(1-2):132-6. PubMed ID: 22857990 [Abstract] [Full Text] [Related]
13. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Jellinger KA. Acta Neuropathol; 2003 May 15; 105(5):415-9. PubMed ID: 12677440 [Abstract] [Full Text] [Related]
14. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease. Pavlovic AM, Pekmezovic T, Obrenovic R, Novakovic I, Tomic G, Mijajlovic M, Sternic N. Clin Neurol Neurosurg; 2011 Nov 15; 113(9):711-5. PubMed ID: 21802199 [Abstract] [Full Text] [Related]
15. Visual rating of white matter hyperintensities in Parkinson's disease. Beyer MK, Aarsland D, Greve OJ, Larsen JP. Mov Disord; 2006 Feb 15; 21(2):223-9. PubMed ID: 16161159 [Abstract] [Full Text] [Related]
16. Quantitative vascular pathology and phenotyping familial and sporadic cerebral small vessel diseases. Craggs LJ, Hagel C, Kuhlenbaeumer G, Borjesson-Hanson A, Andersen O, Viitanen M, Kalimo H, McLean CA, Slade JY, Hall RA, Oakley AE, Yamamoto Y, Deramecourt V, Kalaria RN. Brain Pathol; 2013 Sep 15; 23(5):547-57. PubMed ID: 23387519 [Abstract] [Full Text] [Related]
17. Calcium, magnesium and aluminum concentrations in Parkinson's disease. Yasui M, Kihira T, Ota K. Neurotoxicology; 1992 Sep 15; 13(3):593-600. PubMed ID: 1475063 [Abstract] [Full Text] [Related]
18. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, Dwyer MG, Tysnes OB, Benedict RH, Kelemen A, Bronnick K, Zivadinov R. Mov Disord; 2009 Nov 15; 24(15):2233-41. PubMed ID: 19768730 [Abstract] [Full Text] [Related]
19. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, Jaschke W, Poewe W, Wenning GK. Neuroimage; 2004 Apr 15; 21(4):1443-51. PubMed ID: 15050569 [Abstract] [Full Text] [Related]
20. Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions. Forsberg KME, Zhang Y, Reiners J, Ander M, Niedermayer A, Fang L, Neugebauer H, Kassubek J, Katona I, Weis J, Ludolph AC, Del Tredici K, Braak H, Yilmazer-Hanke D. Acta Neuropathol Commun; 2018 Nov 23; 6(1):128. PubMed ID: 30470258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]